BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brandler JB, Sweetser S, Khoshbin K, Babameto M, Prokop LJ, Camilleri M. Colonic Manifestations and Complications Are Relatively Under-Reported in Systemic Sclerosis: A Systematic Review. Am J Gastroenterol. 2019;114:1847-1856. [PMID: 31805016 DOI: 10.14309/ajg.0000000000000397] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Dein EJ, Wigley FM, McMahan ZH. Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis. BMC Gastroenterol 2021;21:174. [PMID: 33858329 DOI: 10.1186/s12876-021-01738-0] [Reference Citation Analysis]
2 Carr ZJ, Klick J, McDowell BJ, Charchaflieh JG, Karamchandani K. An Update on Systemic Sclerosis and its Perioperative Management. Curr Anesthesiol Rep 2020;:1-10. [PMID: 32904358 DOI: 10.1007/s40140-020-00411-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Lescoat A, Murphy SL, Roofeh D, Pauling JD, Hughes M, Sandler R, Zimmermann F, Wessel R, Townsend W, Chung L, Denton CP, Merkel PA, Steen V, Allanore Y, Del Galdo F, Godard D, Cella D, Farrington S, Buch MH, Khanna D. Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes. J Scleroderma Relat Disord 2021;6:66-76. [PMID: 34316516 DOI: 10.1177/2397198320961967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Constantin A, Achim F, Spinu D, Socea B, Predescu D. Idiopathic Megacolon-Short Review. Diagnostics (Basel) 2021;11:2112. [PMID: 34829459 DOI: 10.3390/diagnostics11112112] [Reference Citation Analysis]
5 Cheah JX, Khanna D, Mcmahan ZH. Management of scleroderma gastrointestinal disease: Lights and shadows. Journal of Scleroderma and Related Disorders. [DOI: 10.1177/23971983221086343] [Reference Citation Analysis]
6 Delaney FT, Fenlon HM, Buckley B, Welaratne I, Cronin CG. Multimodality imaging of the gastrointestinal manifestations of scleroderma. Clin Radiol 2021;76:640-9. [PMID: 34108098 DOI: 10.1016/j.crad.2021.04.014] [Reference Citation Analysis]
7 McMahan ZH, Tucker AE, Perin J, Volkmann ER, Kulkarni S, Ziessman HA, Pasricha PJ, Wigley FM. The relationship between gastrointestinal transit, Medsger GI severity, and UCLA GIT 2.0 symptoms in patients with systemic sclerosis. Arthritis Care Res (Hoboken) 2020. [PMID: 33064934 DOI: 10.1002/acr.24488] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kaniecki T, Abdi T, McMahan ZH. Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis. Med Res Arch 2020;8:2252. [PMID: 34337149 DOI: 10.18103/mra.v8i10.2252] [Reference Citation Analysis]
9 Luquez-Mindiola A, Atuesta AJ, Gómez-Aldana AJ. Gastrointestinal manifestations of systemic sclerosis: An updated review. World J Clin Cases 2021; 9(22): 6201-6217 [PMID: 34434988 DOI: 10.12998/wjcc.v9.i22.6201] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 McMahan ZH, Khanna D. Managing gastrointestinal complications in patients with systemic sclerosis. Curr Treat Options Gastroenterol 2020;18:531-44. [PMID: 34305387 DOI: 10.1007/s11938-020-00314-x] [Reference Citation Analysis]